Description
SWOT ANALYSIS OF ELI LILLY
Eli Lilly
Parent Company
Eli Lilly & Co
Category
Pharmaceutical & chemical
Sector
Health Care
Tagline/ Slogan
Transforming challenges in advances
Lilly makes medicines that help people live longer, healthier, more USP active lives.
STP
They operate in Oncology, cardiovascular diseases, diabetes, critical Segment care, neuroscience, men’s health, and musculoskeletal segments.
Healthcare professionals offering solutions to patients suffering from Target Group oncology, diabetes, neuroscience
Lilly makes medicines that help people live longer, healthier, more Positioning active lives.
SWOT Analysis
1. Strong capability to create strategic alliances & marketing partnerships with other corporations 2. Strong marketing ability such as 60 second commercial plot for drug Cialis 3. Well developed in house R&D capability 4. Global footprint & ability to sell drugs all over the world 5. They employ more than 7000 people in LRL spanning 50 countries 6. Products available in over 125 countries and has close to 40,000 Strength employees
1. Loss of patents in US & other major markets affects performance 2. Drop sales because of new generic products 3. Eli lilly has captured fragmented market shares which prevents it Weakness from becoming market leader
Opportunity
1. Improvement global living standards
2. Increasing awareness about healthcare needs 3. Global societies growing older
1. Over the years there is considerable increase in generic 2. Economic slow down Threats 3. Increased hurdles for drug discovery & development
Competition
1. Pfizer Inc 2. Sanofi Aventis 3. AstraZeneca plc 4. GlaxoSmithKline 5. Bristol Myers 6. Merck & Co Inc. Competitors 7. Roche Holding Ltd
doc_261434085.docx
SWOT ANALYSIS OF ELI LILLY
Eli Lilly
Parent Company
Eli Lilly & Co
Category
Pharmaceutical & chemical
Sector
Health Care
Tagline/ Slogan
Transforming challenges in advances
Lilly makes medicines that help people live longer, healthier, more USP active lives.
STP
They operate in Oncology, cardiovascular diseases, diabetes, critical Segment care, neuroscience, men’s health, and musculoskeletal segments.
Healthcare professionals offering solutions to patients suffering from Target Group oncology, diabetes, neuroscience
Lilly makes medicines that help people live longer, healthier, more Positioning active lives.
SWOT Analysis
1. Strong capability to create strategic alliances & marketing partnerships with other corporations 2. Strong marketing ability such as 60 second commercial plot for drug Cialis 3. Well developed in house R&D capability 4. Global footprint & ability to sell drugs all over the world 5. They employ more than 7000 people in LRL spanning 50 countries 6. Products available in over 125 countries and has close to 40,000 Strength employees
1. Loss of patents in US & other major markets affects performance 2. Drop sales because of new generic products 3. Eli lilly has captured fragmented market shares which prevents it Weakness from becoming market leader
Opportunity
1. Improvement global living standards
2. Increasing awareness about healthcare needs 3. Global societies growing older
1. Over the years there is considerable increase in generic 2. Economic slow down Threats 3. Increased hurdles for drug discovery & development
Competition
1. Pfizer Inc 2. Sanofi Aventis 3. AstraZeneca plc 4. GlaxoSmithKline 5. Bristol Myers 6. Merck & Co Inc. Competitors 7. Roche Holding Ltd
doc_261434085.docx